These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 9010682)
41. The cytokine milieu of HIV-associated non-Hodgkin's lymphoma favours aggressive tumours. Duff DK; Thompson S; Braye S; Price D; Loewenthal M; Boyle MJ AIDS; 2000 Jan; 14(1):92-4. PubMed ID: 10714574 [No Abstract] [Full Text] [Related]
42. Reactive iris lymphoid proliferation presenting as the AIDS-defining event in an HIV patient with systemic lymphoma. Mathur R; Lim WK; Chan CC; Chee SP AIDS; 2004 Nov; 18(16):2215-6. PubMed ID: 15577661 [No Abstract] [Full Text] [Related]
43. Lack of association between HCV infection and HIV-related lymphoma. Besson C; Pialoux G; Dupont B; Pol S; Hermine O; Arnulf B; Landau A; McCormick JB Br J Haematol; 1999 May; 105(2):568-9. PubMed ID: 10233441 [No Abstract] [Full Text] [Related]
44. A review of the association between interleukin-10 and human B-cell malignancies. Khatri VP; Caligiuri MA Cancer Immunol Immunother; 1998 Jul; 46(5):239-44. PubMed ID: 9690451 [No Abstract] [Full Text] [Related]
45. Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial). Epeldegui M; Lee JY; MartÃnez AC; Widney DP; Magpantay LI; Regidor D; Mitsuyasu R; Sparano JA; Ambinder RF; MartÃnez-Maza O Clin Cancer Res; 2016 Jan; 22(2):328-36. PubMed ID: 26384320 [TBL] [Abstract][Full Text] [Related]
46. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Shin HD; Winkler C; Stephens JC; Bream J; Young H; Goedert JJ; O'Brien TR; Vlahov D; Buchbinder S; Giorgi J; Rinaldo C; Donfield S; Willoughby A; O'Brien SJ; Smith MW Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14467-72. PubMed ID: 11121048 [TBL] [Abstract][Full Text] [Related]
47. Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma. Sei S; O'Neill DP; Stewart SK; Yang Q; Kumagai M; Boler AM; Adde MA; Zwerski SL; Wood LV; Venzon DJ; Magrath IT Cancer Res; 2001 Jul; 61(13):5028-37. PubMed ID: 11431337 [TBL] [Abstract][Full Text] [Related]
48. [Clinical observation of the changes of serum helper T-lymphocytes (TH) cytokines in patients with HIV-infection and opportunistic infection]. Rao HP; Feng L; Li D; Bader A; Wu NP Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jan; 41(1):42-5. PubMed ID: 17484210 [TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS. Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996 [TBL] [Abstract][Full Text] [Related]
50. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders. Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202 [TBL] [Abstract][Full Text] [Related]